Mark Lebovitch Speaks at PLI's Annual Program on Delaware Corporate Law Developments

May 21, 2008

BLB&G Partner Mark Lebovitch participated at the PLI program entitled, “What All Business Lawyers Must Know About Delaware Law Developments 2008,” which was held on May 21, 2008 in PLI’s New York Center.

This is an annual program which focuses on the most recent and important Delaware corporate law developments, their impact on business practices and legal implications.  Joining other experts, including those from the judiciary, leading law firms and corporations, institutional investors and academics, Mr. Lebovitch drew from his experience as an attorney specializing in corporate transaction litigation to discuss the latest case law and trends, share his real-world experience, and provide insights and practical advice on the issues of great concern to the corporate/securities legal community.

Mr. Lebovitch is one of the partners primarily responsible for the Firm's corporate transaction litigation practice.  In that role, he has helped to obtain for shareholders billions of dollars in additional consideration and significant corporate governance improvements by asserting breach of fiduciary duty claims arising from, among other things, the hostile takeover battles over Caremark Rx, Inc. and CBOT Holdings, Inc., the private equity buyout of Ceridian Corporation, the acquisition of Commerce Bancorp., and the going private proposal for Cablevision Systems Corporation.  Mr. Lebovitch is a member of the Firm's subprime litigation team, which focuses on vindicating shareholder and consumer rights arising from the mortgage and mortgage-based security debt crisis, and is also a member of the teams prosecuting In re Suprema Specialties, Inc. Securities Litigation, and In re Omnicom Group, Inc. Securities Litigation.


New York, New York